Related Experiment Videos
National and Regional Lifetime Risk of Developing and Dying from Lung Cancer - China, 2023
Qian Mao1,2, Zhenping Zhao2, Maigeng Zhou2
1Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan City, Shandong Province, China.
Introduction:
Lung cancer is the most commonly diagnosed malignancy and the leading cause of cancer-related mortality in China. However, the lifetime risk (LTR) of lung cancer in China remains poorly understood. This study aimed to provide national and regional estimates of LTR of lung cancer in China in 2023.
Methods:
Lung cancer incidence and mortality data were sourced from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023. Population data were obtained from the China Statistical Yearbook and national census records. The lung cancer LTR was calculated using a standardized approach that accounts for multiple primary cancers.
Results:
In 2023, the LTR of developing lung cancer in China was 6.52% [95% uncertainty interval (UI): 6.28, 6.56], while the LTR of dying from lung cancer was 5.98% (95% UI: 5.57, 6.26). Sex-specific analysis indicated that males had a higher risk, with 8.28% (95% UI: 7.74, 8.38) for developing and 7.61% (95% UI: 6.71, 8.19) for death, compared to 4.52% (95% UI: 4.30, 4.74) and 4.14% (95% UI: 3.81, 4.51), respectively, in females. The remaining LTR of lung cancer declined as the age at diagnosis increased. Marked geographic disparities were observed; the highest LTR was found in the northeastern region, followed by the eastern, northern, south-central, and southwestern regions, while the northwestern region had the lowest risk.
Conclusion:
The estimated LTR of lung cancer in China is approximately one in 15 individuals and one in 17 deaths. The substantial regional variations in lung cancer risk highlight the need for targeted cancer control strategies and tailored healthcare planning.
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Cancer Prevention
Some...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Cancer Survival Analysis